急诊应用胺碘酮治疗冠心病快速心律失常的临床疗效

Clinical efficacy of amiodarone in emergency treatment of tachyarrhythmia in patients with coronary heart disease

目的探讨在冠心病快速心律失常患者临床治疗过程中,急诊应用胺碘酮治疗的应用效果。方法主要选择2014年3月至2015年3月我院收治的冠心病快速心律失常患者100例,随机分成两个组,对照组患者主要进行临床基础治疗,观察组患者在对照组治疗基础上加以胺碘酮急诊治疗。结果经过两组患者临床治疗,在患者临床治疗有效情况上,观察组明显优于对照组,在患者心率和心电图监测指标上,观察组明显优于对照组,且在患者后期不良反应发生情况上,观察组也明显优于对照组。结论对于冠心病快速心律失常患者来说,应用胺碘酮药物进行治疗十分有效,不仅可以明显改善患者心率等相关指标,还可以在降低患者后期不良反应发生率的基础上促进患者病情痊愈。

Objective To investigate the clinical efficacy of amiodarone in the emergency treatment of tachyarrhythmia in patients with coronary heart disease (CHD). Methods A total of 100 CHD patients with tachyarrhythmia who were admitted to our hospital from March 2014 to March 2015 were enrolled and randomized into two groups. The patients in the control group received clinical basic treatment, and those in the observation group received emergency treatment with amiodarone in addition to the clinical basic treatment. Results After clinical treatment, compared with the control group, the observation group had a better clinical outcome, better improvements in heart rate and indicators of electrocardiogram monitoring, and a lower incidence of adverse events. Conclusion For CHD patients with tachyarrhythmia, amiodarone has a good therapeutic effect, and can improve the indicators such as heart rate, reduce the incidence of adverse events, and promote recovery.